23 Million tests conducted and 15.74 Million lives impacted
97% reduction in mortality across 126 remote areas
In less than a minute
Arficus, a Fund III portfolio company of Pontaq, is a pioneering healthcare technology startup committed to revolutionizing healthcare with its AI-powered disease screening, diagnostics, and prediction SaaS-SaMD platform, MEDHINI. The software can be integrated with existing X-ray, CT scan, mammogram, ultrasound, MRI, Doppler, pathology machines, and more.
Based in a Tier II city in Rajasthan, Arficus has quickly expanded its flagship product, MEDHINI, into a groundbreaking AI-driven healthcare solution. MEDHINI serves five key verticals: Neurology, Nephrology, Cardiology, Oncology, and Pulmonology. The company has achieved significant milestones, including clinical certification with an impressive accuracy rate of 99.31%. MEDHINI can diagnose 203 diseases by analyzing 314 biomarkers and vital annotations.
MEDHINI software can be utilized by various healthcare facilities including hospitals, nursing homes, clinics, and primary health centers. It also serves biopharma companies in drug discovery, insurance companies for underwriting and claims settlement, and corporates for employee wellness and well-being programs. Additionally, Arficus has collaborated with state and central governments on multiple health checkup programs. This includes subsidized testing across 15 districts across Chhattisgarh and Madhya Pradesh in partnership with the state government.
Founded in 2019 by IIT Kharagpur alumni Sandeep Sinha and Anurag Jain, MEDHINI has already achieved remarkable growth. Featured as one of the top 5 finalists in the Leap To Unicorn Season 1 on CNBC, the company has expanded its presence to 14 countries and has attracted around 200 clients. In the financial year 2023-24, MEDHINI achieved an impressive annual revenue of $5.1 million in FY 24, a 5X increase from the previous year. The company is now projecting a revenue of atleast $12 Mn with 500 clients in the current financial year.
MEDHINI is creating the world’s first Human Health Climate Change Cross Prediction Platform. This platform aims to predict how climate change affects human health and the emergence of new diseases due to climate changes, allowing for early diagnosis and prevention.
As Sandeep, co-founder and CEO, Arficus quotes “MEDHINI is the next generation revolution in the field of public’s equitable and affordable healthcare, where we harness the power of Artificial Intelligence to enable informed decision making. We at MEDHINI want to make India a Global Leader in Healthcare and the vision of Atamnirbhar Bharat and Viksit Bharat a reality.”
As MEDHINI continues to innovate in healthcare technology, its global impact grows. By making advanced disease diagnostics affordable and accessible, Arficus is transforming healthcare for millions. Stay tuned for more updates on their groundbreaking journey.
To learn more about Arficus, visit https://arficus.com/
Together we grow!
Team Pontaq